Question 1

What are the potential benefits of switching to avelumab after my initial chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) clinical trial (NCT02625610). Contact the study team or your healthcare provider for specific answers.

Question 2

How does avelumab compare to my current treatment in terms of side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) clinical trial (NCT02625610). Contact the study team or your healthcare provider for specific answers.

Question 3

What monitoring will be required if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) clinical trial (NCT02625610). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with participating in this trial that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) clinical trial (NCT02625610). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in the trial, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) clinical trial (NCT02625610). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if my cancer progresses while I'm on this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) clinical trial (NCT02625610). Contact the study team or your healthcare provider for specific answers.

What this study is about